Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 124 | 1 | 135 | +12 |
| Shares | 24.3M | 9.32K | 25.0M | +702.0K (+2.9%) |
| Value | $187.3M | $72.0K | $167.9M | −$19.4M (−10.3%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 77,269 | $519.2K | 0.00% |
| Ameriprise Financial Inc | 65,282 | $438.7K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 43,291 | $290.9K | 0.01% |
| XTX Topco Ltd | 29,282 | $196.8K | 0.00% |
| Schonfeld Strategic Advisors LLC | 26,315 | $176.8K | 0.00% |
| Apollon Wealth Management, LLC | 23,433 | $157.5K | 0.00% |
| Mariner, LLC | 20,555 | $138.1K | 0.00% |
| Walleye Capital LLC | 19,323 | $129.9K | 0.00% |
| CI Private Wealth, LLC | 17,354 | $116.6K | 0.00% |
| Abel Hall, LLC | 16,142 | $108.5K | 0.02% |
| Dynamic Technology Lab Private Ltd | 15,177 | $102.0K | 0.02% |
| Raymond James Financial Inc | 14,323 | $96.3K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 13,282 | $92.6K | 0.00% |
| Diversify Advisory Services, LLC | 15,785 | $90.9K | 0.00% |
| Two Sigma Securities, LLC | 11,864 | $79.7K | 0.01% |
| Nisa Investment Advisors, LLC | 3,300 | $22.2K | 0.00% |
| Global Retirement Partners, LLC | 672 | $4.52K | 0.00% |
| Fortitude Family Office, LLC | 134 | $900 | 0.00% |
| Parkside Financial Bank & Trust | 80 | $538 | 0.00% |
| Clearstead Advisors, LLC | 55 | $370 | 0.00% |
Sold out (8)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Odyssean, LLC | 22,956 | $177.2K |
| SG Americas Securities, LLC | 20,972 | $162.0K |
| Castleview Partners, LLC | 16,857 | $130.1K |
| HRT Financial LP | 15,129 | $116.0K |
| ADAR1 Capital Management, LLC | 15,000 | $115.8K |
| MAI Capital Management | 465 | $3.59K |
| Wealth Preservation Advisors, LLC | 40 | $309 |
| Root Financial Partners, LLC | 22 | $170 |
Not filed for Q2 2026 yet (1)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 9,324 | $72.0K |